Dorit Samocha-Bonet
Overview
Explore the profile of Dorit Samocha-Bonet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wark G, Kaakoush N, Samocha-Bonet D, Ghaly S, Danta M
Nutrients
. 2024 Oct;
16(19).
PMID: 39408201
Diet has been linked to gut dysbiosis and the onset, course, and response to treatment of patients with IBD and metabolic disease. : This single-centre prospective case-control study investigated the...
2.
Katsoudas N, Tavakoli P, Wu N, Shapiro A, Leach S, Williams A, et al.
Inflamm Bowel Dis
. 2024 Jan;
30(8):1241-1250.
PMID: 38244236
Background: Emulsifiers are implicated in the pathogenesis of inflammatory bowel disease (IBD). Few studies have examined emulsifier intake in people with existing IBD. We aimed to describe the frequency of...
3.
Shalaby N, Samocha-Bonet D, Kaakoush N, Danta M
Pathogens
. 2023 Sep;
12(9).
PMID: 37764895
Liver disease is a major global health problem leading to approximately two million deaths a year. This is the consequence of a number of aetiologies, including alcohol-related, metabolic-related, viral infection,...
4.
Koay Y, Coster A, Chen D, Milner B, Batarseh A, OSullivan J, et al.
Metabolites
. 2022 Dec;
12(12).
PMID: 36557310
The liver, skeletal muscle, and adipose tissue are major insulin target tissues and key players in glucose homeostasis. We and others have described diverse insulin resistance (IR) phenotypes in people...
5.
Samocha-Bonet D, Wu B, Ryugo D
Ageing Res Rev
. 2021 Aug;
71:101423.
PMID: 34384902
Diabetes (type 2) and sensorineural hearing loss are common health problems manifested with ageing. While both type 1 and type 2 diabetes have been associated with hearing loss, a causal...
6.
Lambert K, Pappas D, Miglioretto C, Javadpour A, Reveley H, Frank L, et al.
Aliment Pharmacol Ther
. 2021 Jul;
54(6):742-754.
PMID: 34323292
Background: Poor dietary intake is associated with the development of malnutrition, micronutrient deficiencies, anaemia and osteoporosis in individuals with inflammatory bowel disease. While trials are underway to manipulate the diet...
7.
Snaith J, Samocha-Bonet D, Evans J, Liu Z, Kowalski G, Bruce C, et al.
Diabet Med
. 2021 Mar;
38(9):e14564.
PMID: 33774848
Background: Insulin resistance is an under-recognised metabolic defect and cardiovascular risk factor in Type 1 diabetes. Whether metformin improves hepatic, muscle or adipose tissue insulin sensitivity has not been studied...
8.
Williams A, Paramsothy R, Wu N, Ghaly S, Leach S, Paramsothy S, et al.
BMJ Open
. 2021 Feb;
11(2):e042493.
PMID: 33593778
Introduction: Crohn's disease and ulcerative colitis are common chronic idiopathic inflammatory bowel diseases (IBD), which cause considerable morbidity. Although the precise mechanisms of disease remain unclear, evidence implicates a strong...
9.
Wark G, Samocha-Bonet D, Ghaly S, Danta M
Nutrients
. 2021 Jan;
13(1).
PMID: 33396537
Inflammatory bowel diseases, which include ulcerative colitis and Crohn's disease, are chronic relapsing and remitting inflammatory diseases of the gastrointestinal tract that are increasing in prevalence and incidence globally. They...
10.
Bishay R, Tonks K, George J, Samocha-Bonet D, Meyerowitz-Katz G, Chisholm D, et al.
J Clin Endocrinol Metab
. 2020 Dec;
106(3):e1131-e1139.
PMID: 33347566
Context: The etiological mechanism of bile acid (BA) effects on insulin resistance and obesity is unknown. Objective: This work aimed to determine whether plasma BAs are elevated in human obesity...